Models of CHD2
As part of our "Roadmap to a Cure", we must ensure that any treatment we intend to use in people will be safe, efficacious and has the greatest potential to benefit people living with a CHD2 mutation.
For these reasons, developing models of CHD2 that can be widely shared with the fewest barriers or commercially purchased is a top priority for our community.
Listed below is a growing list of models that can be used as tools for basic biology and translational-preclinical studies of CHD2.
CHD2 human iPSC line available through the European Bank for Induced Pluripotent Stem Cells
PFIZi029-A Description: c4636 C>T in exon 36 of the CHD2 gene (NM_001271.3)
CHD2 human stable knockdown cell lines through AcceGen Biotech
Human CHD2 shRNA knockdown in HEK293 or HeLa cells
CHD2 mouse model that has 2 nucleotide deletion in the 3rd exon of CHD2, which leads to production of little to no CHD2 protein.
Dr. Igor Ulitsky has a mouse model that has 2 nucleotide deletions in the 3rd exon of CHD2, which leads to production of little to no CHD2 protein. See his paper for more details: https://www.nature.com/articles/s41467-019-13075-8.pdf
Chd2 mouse alleles available through The International Mouse Phenotyping Consortium and related phenotypic data
Chd2 tm1 targeting vectors and ES cells Allele type: reporter-tagged deletion allele (with selection cassette)
Chd2 tm1a mice, targeting vectors, and ES cells Allele type: KO first allele (reporter-tagged insertion with conditional potential)
Chd2 tm1b mice and tissue available through The Centre for Phenogenomics Allele type: Reporter-tagged deletion allele (post-Cre)
Chd2 mouse alleles available through Taconic Biosciences, Inc.
Chd2 constitutive knockout Allele type: Gene trap
Chd2 zebrafish line available through The Zebrafish Information Network: MO1-chd2
Chd2 zebrafish line available through UCSF, Scott Baraban Lab https://zebrafishproject.ucsf.edu/chd2
CHD2 mutant frog allele with a 22bp deletion within the second chromodomain, though not yet published.
For inquiries and additional information please contact, Helen Willsey, PhD @ Helen.Willsey@ucsf.edu
Stock will be distributed through the National Xenopus Resource (NXR)
Have you or your loved one been diagnosed with CHD2?
Register hereOngoing Studies
Participating in a data collection program is one of the most important things that families with a child with CHD2-related neurodevelopmental disorders can do.
Read moreThis study aims to understand seizures, communication and daily living of adults with CHD2 mutations.
Read moreNatural History Studies (NHS) are critical to the drug development process. Citizen Health has developed a new method to make this process easier.
Read MoreVideos